Table 1.
Initial assessment | Follow-upa | Treatment termination | Regimen change | Transfer of clinical care | |
---|---|---|---|---|---|
Patient name and ID | X | X | X | X | X |
Current treatment ID | X | X | X | X | X |
Treatment site location code | X | X | X | X | X |
Patient demographics | |||||
Age | X | ||||
Gender | X | ||||
Marital status | X | ||||
Examination | |||||
Pre-treatment symptomsb | X | ||||
Body weight | X | X | |||
Laboratory test resultsc | X | X | |||
HIV status | |||||
Date of HIV diagnosis | X | ||||
Route of HIV infection | X | ||||
Treatment status | |||||
Duration of follow-up | X | X | |||
ART payment source | X | ||||
ART regimens at initiation | X | ||||
Previous use of Chinese medicine to treat HIV | X | ||||
Current ART regimen | X | X | X | ||
Current regimen initiation date | X | X | |||
Self-reported adherence | X | ||||
ART adverse side effects | X | ||||
Spouse ART status | X | ||||
Date of regimen change | X | ||||
Reason for regimen change | X | ||||
Previous medication stoppage | X | ||||
Time elapsed since stopping previous regimen | X | X | |||
Termination | |||||
Type of terminationd | X | ||||
Cause of termination | X | ||||
Date of termination event | X | ||||
Cause of death | X | ||||
Adverse side effects caused by termination | X |
aFollow-up is performed at 0.5, 1, 2 and 3 months after ART initiation, once every 3 months thereafter.
bThese include herpes zoster, fever, chronic diarrhoea, odynophagia and weight loss.
cLaboratory tests include CD4 count, viral load, haematology, immunology, liver function.
dMortality, medication discontinuation, lost to follow-up, transfer of clinical care.